Fassas A - Search Results

1

Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival.

Zangari M, Barlogie B, Thertulien R, Jacobson J, Eddleman P, Fink L, Fassas A, Van Rhee F, Talamo G, Lee CK, Tricot G. Zangari M, et al. Among authors: fassas a. Clin Lymphoma. 2003 Jun;4(1):32-5. doi: 10.3816/clm.2003.n.011. Clin Lymphoma. 2003. PMID: 12837152

2

Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients.

Fassas AB, Spencer T, Desikan R, Zangari M, Anaissie E, Barlogie B, Tricot G. Fassas AB, et al. Br J Haematol. 2002 Oct;119(1):164-8. doi: 10.1046/j.1365-2141.2002.03772.x. Br J Haematol. 2002. PMID: 12358921 Free article. Clinical Trial.

3

Predicting long-term survival in multiple myeloma patients following autotransplants.

Fassas AB, Van Rhee F, Tricot G. Fassas AB, et al. Leuk Lymphoma. 2003 May;44(5):749-58. doi: 10.1080/1042819031000067567. Leuk Lymphoma. 2003. PMID: 12802910 Review.

4

Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience.

Fassas AB, Barlogie B, Ward S, Jagannath S, Vesole D, Mattox S, Siegel D, Muwalla F, Zangari M, Anaissie E, Rhee FV, Thertulien R, Lee CK, Desikan R, Arzumanian V, McCoy J, Tricot G. Fassas AB, et al. Br J Haematol. 2003 Nov;123(3):484-9. doi: 10.1046/j.1365-2141.2003.04646.x. Br J Haematol. 2003. PMID: 14617011 Free article.

5

Chromosome 13 deletion/hypodiploidy and prognosis in multiple myeloma patients.

Fassas AB, Tricot G. Fassas AB, et al. Leuk Lymphoma. 2004 Jun;45(6):1083-91. doi: 10.1080/10428190310001642710. Leuk Lymphoma. 2004. PMID: 15359986 Review.

6

Tandem transplants in the treatment of multiple myeloma. Pro.

Fassas AB, Tricot G. Fassas AB, et al. Clin Adv Hematol Oncol. 2004 May;2(5):303-4. Clin Adv Hematol Oncol. 2004. PMID: 17682284 Review. No abstract available.

7

Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants.

Tricot G, Spencer T, Sawyer J, Spoon D, Desikan R, Fassas A, Badros A, Zangari M, Munshi N, Anaissie E, Toor A, Barlogie B. Tricot G, et al. Among authors: fassas a. Br J Haematol. 2002 Jan;116(1):211-7. doi: 10.1046/j.1365-2141.2002.03231.x. Br J Haematol. 2002. PMID: 11841419 Free article.

8

Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning.

Badros A, Barlogie B, Siegel E, Cottler-Fox M, Zangari M, Fassas A, Morris C, Anaissie E, Van Rhee F, Tricot G. Badros A, et al. Among authors: fassas a. J Clin Oncol. 2002 Mar 1;20(5):1295-303. doi: 10.1200/JCO.2002.20.5.1295. J Clin Oncol. 2002. PMID: 11870172

9

Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy.

Zangari M, Siegel E, Barlogie B, Anaissie E, Saghafifar F, Fassas A, Morris C, Fink L, Tricot G. Zangari M, et al. Among authors: fassas a. Blood. 2002 Aug 15;100(4):1168-71. doi: 10.1182/blood-2002-01-0335. Blood. 2002. PMID: 12149193 Free article. Clinical Trial.

10

Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II.

Shaughnessy J Jr, Tian E, Sawyer J, McCoy J, Tricot G, Jacobson J, Anaissie E, Zangari M, Fassas A, Muwalla F, Morris C, Barlogie B. Shaughnessy J Jr, et al. Among authors: fassas a. Br J Haematol. 2003 Jan;120(1):44-52. doi: 10.1046/j.1365-2141.2003.03948.x. Br J Haematol. 2003. PMID: 12492575 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page